LeukoDx Closes $1.6M Financing Tranche, Inks Agreements for up to $8M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Flow cytometry technology firm LeukoDx today announced it has secured commitments of up to $8 million in investments during the next three years.

The funding is expected to bring the company's development of its point-of-care platform to the point of registration, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.